Table 1.
Median | Range | |
---|---|---|
Age at Diagnosis (years) | 58.8 | 39.6–72.4 |
Pre-Biopsy PSA (ng/mL) | 4.9 | 0.8–35.9 |
Clinical Stage | Number | % |
T1c | 155 | 59.16 |
T2 unspecified | 6 | 2.29 |
T2a | 32 | 12.21 |
T2b | 16 | 6.11 |
T2c | 35 | 13.36 |
T3a | 15 | 5.73 |
T3b | 1 | 0.38 |
T4 | 2 | 0.76 |
Biopsy Gleason Score | Number | % |
3+3 | 178 | 67.94 |
3+4 | 49 | 18.70 |
4+3 | 22 | 8.40 |
4+4 | 10 | 3.82 |
4+5 | 3 | 1.14 |
Median | Range | |
Number of Negative Cores (NNC) | 9.0 | 0.0–29.0 |
Number of Positive Cores (NPC) | 2.0 | 1.0–14.0 |
Percent of Cores Positive | 20.0 | 3.7–100.0 |